- Home
- ZION vs BRKR Comparison
ZION vs BRKR Comparison
Compare ZION & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- BRKR
- Stock Information
- Founded
- ZION 1873
- BRKR 1991
- Country
- ZION United States
- BRKR United States
- Employees
- ZION N/A
- BRKR N/A
- Industry
- ZION Major Banks
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- ZION Finance
- BRKR Industrials
- Exchange
- ZION Nasdaq
- BRKR Nasdaq
- Market Cap
- ZION 8.6B
- BRKR 9.2B
- IPO Year
- ZION N/A
- BRKR 2000
- Fundamental
- Price
- ZION $59.03
- BRKR $60.07
- Analyst Decision
- ZION Hold
- BRKR Buy
- Analyst Count
- ZION 19
- BRKR 13
- Target Price
- ZION $57.06
- BRKR $76.00
- AVG Volume (30 Days)
- ZION 1.4M
- BRKR 1.4M
- Earning Date
- ZION 01-21-2025
- BRKR 02-11-2025
- Dividend Yield
- ZION 2.92%
- BRKR 0.33%
- EPS Growth
- ZION N/A
- BRKR N/A
- EPS
- ZION 4.39
- BRKR 2.06
- Revenue
- ZION $3,010,000,000.00
- BRKR $3,241,300,000.00
- Revenue This Year
- ZION N/A
- BRKR $15.23
- Revenue Next Year
- ZION $3.73
- BRKR $7.52
- P/E Ratio
- ZION $13.46
- BRKR $29.14
- Revenue Growth
- ZION N/A
- BRKR 15.00
- 52 Week Low
- ZION $37.76
- BRKR $48.07
- 52 Week High
- ZION $63.22
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- ZION 62.38
- BRKR 52.88
- Support Level
- ZION $56.35
- BRKR $54.60
- Resistance Level
- ZION $58.91
- BRKR $64.64
- Average True Range (ATR)
- ZION 1.40
- BRKR 2.91
- MACD
- ZION 0.56
- BRKR -0.16
- Stochastic Oscillator
- ZION 98.89
- BRKR 54.48
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.